The role of ERCC2 polymorphisms in breast cancer risk

Cancer Genetics and Cytogenetics

Volumn 170, Issue 1, 2006, Pages 86-88

  Silva, Susana N ^a   Bezerra de Castro, Guilherme ^b   Faber, Ana ^a   Pires, Marcelo ^b   Oliveira, Vanessa C ^a   Azevedo, Ana Paula ^c   Cabral, Marisa N ^a   Manita, Isabel ^d   Pina, Julieta Esperança ^c   Rueff, José ^a   Gaspar, Jorge ^a  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b Molecular Cancer Research Center   (Brazil)

^c HOSPITAL DE SÃO FRANCISCO XAVIER   (Portugal)

^d HOSPITAL GARCIA DE ORTA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; AMINO ACID SUBSTITUTION; BRAZIL; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; DNA REPAIR; ERCC2 GENE; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HUMAN; LETTER; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING;

ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 33748494210     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.04.017     Document Type: Letter

References (14)

1. Hemminki K., Xu G., Angelini S., Snellman E., Jansen C.T., Lambert B., and Hou S.M. XPD exon 10 and 23 polymorphisms and DNA repair in human skin in situ. Carcinogenesis 22 (2001) 1185-1188
2. Justenhoven C., Hamann U., Pesch B., Harth V., Rabstein S., Baisch C., Vollmert C., Illig T., Ko Y.D., Bruning T., and Brauch H. ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Cancer Epidemiol Biomarkers Prev 13 (2004) 2059-2064
3. Kuschel B., Chenevix-Trench G., Spurdle A.B., Chen X., Hopper J.L., Giles G.G., McCredie M., Chang-Claude J., Gregory C.S., Day N.E., Easton D.F., Ponder B.A., Dunning A.M., and Pharoah P.D. Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk. Cancer Epidemiol Biomarkers Prev 14 (2005) 1828-1831
4. Lee S.A., Lee K.M., Park W.Y., Kim B., Nam J., Yoo K.Y., Noh D.Y., Ahn S.H., Hirvonen A., and Kang D. Obesity and genetic polymorphism of ERCC2 and ERCC4 as modifiers of risk of breast cancer. Exp Mol Med 37 (2005) 86-90
5. Silva S.N., Gil O.M., Oliveira V.C., Cabral M.N., Azevedo A.P., Faber A., Manita I., Ferreira T.C., Limbert E., Pina J.E., Rueff J., and Gaspar J. Association of polymorphisms in ERCC2 gene with non-familial thyroid cancer risk. Cancer Epidemiol Biomarkers Prev 14 (2005) 2407-2412
6. Castro G.B., Fonte C.J.E., De-Lamonica-Freire E.M., and Hamada G.S. The absence of death by breast cancer among indigenous women living in Mato Grosso, Brazil 2000: protection or undernotification?. J Womens Cancer 3 (2002) 109-112
7. Benhamou S., and Sarasin A. ERCC2/XPD gene polymorphisms and lung cancer: a HuGE review. Am J Epidemiol 161 (2005) 1-14
8. Lange K., Cantor R., Horvath S., Perola M., Sabatti C., Sinsheimer J., and Sobel E. Mendel version 4.0: a complete package for the exact genetic analysis of discrete traits in pedigree and population data sets. [Abstract]. Am J Hum Genet 69 Suppl (2001) A1886
9. Butkiewicz D., Rusin M., Enewold L., Shields P.G., Chorazy M., and Harris C.C. Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis 22 (2001) 593-597
10. Lee K.M., Choi J.Y., Kang C., Kang C.P., Park S.K., Cho H., Cho D.Y., Yoo K.Y., Noh D.Y., Ahn S.H., Park C.G., Wei Q., and Kang D. Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk. Clin Cancer Res 11 (2005) 4620-4626
11. Shi Q., Wang L.E., Bondy M.L., Brewster A., Singletary S.E., and Wei Q. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Carcinogenesis 25 (2004) 1695-1700
12. Tang D., Cho S., Rundle A., Chen S., Phillips D., Zhou J., Hsu Y., Schnabel F., Estabrook A., and Perera F.P. Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case-control study of breast cancer. Breast Cancer Res Treat 75 (2002) 159-166
13. Zhang L., Zhang Z., and Yan W. Single nucleotide polymorphisms for DNA repair genes in breast cancer patients. Clin Chim Acta 359 (2005) 150-155
14. Terry M.B., Gammon M.D., Zhang F.F., Eng S.M., Sagiv S.K., Paykin A.B., Wang Q., Hayes S., Teitelbaum S.L., Neugut A.I., and Santella R.M. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 13 (2004) 2053-2058